Each 0.06 g/L (one SD) increase in baseline fetuin-A concentration was associated with a 14% lower risk of any diabetes complications (HR 0.86, 95% CI 0.74; 0.99) and 16% lower risk of microvascular complications (HR 0.84, 95% CI 0.71; 0.98) in the basic model, Table 2. This evidence concerns the gene AHSG and diabetes mellitus.